NephroDI Therapeutics Funding & Investors
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney. The company was founded in 2017 by Jeff M. Sands, Janet D. Klein, Ish Khanna, and Ram Pillarisetti and is headquartered in Philadelphia, Pennsylvania.
nephrodi.comTotal Amount Raised: $3,600,018
NephroDI Therapeutics Funding Rounds
Series Unknown
$2,000,000
Seed
$1,600,018
Funding info provided by Diffbot.